Topics

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 13, Status: Authorised

07:27 EDT 29 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 13, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 13, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Revestive, teduglutide, Malabsorption Syndromes, Date of authorisation: 30/08/2012, Revision: 13, Status: Authorised"

Quick Search